Literature DB >> 14646526

Life and death decisions: the role of the IAPs in modulating programmed cell death.

P Liston1, S S Young, A E Mackenzie, R G Korneluk.   

Abstract

Multicellular organisms have evolved elaborate signal transduction pathways for maintaining homeostasis through the control of cell proliferation and death. The recent surge of interest in the regulation of programmed cell death has led to the rapid identification of many proteins involved in controlling and executing apoptosis. The inhibitors of apoptosis proteins (IAPs) constitute a family of highly conserved death suppressing proteins that were first identified in baculoviruses, and that has recently expanded to include at least two homologues in Drosophila melanogaster and four in rodents and humans. In this article we review the current state of IAP research. Two of the IAPs, HIAP-1 and HIAP-2, have been placed within the TNFalpha induced cell death pathway which involves two receptors for TNFalpha and multiple, overlapping signal transduction proteins. A third, X-linked gene termed XIAP, is ubiquitously expressed and appears to have a broad range of suppressor activity to a variety of apoptotic triggers. The fourth member, NAIP, has been identified as the protein product of a candidate gene for the inherited neuromuscular disorder, spinal muscular atrophy (SMA). The neuroprotective activity of NAIP in an in vivo model of cerebral ischemia has also been demonstrated.

Entities:  

Year:  1997        PMID: 14646526     DOI: 10.1023/a:1026465926478

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  19 in total

Review 1.  The role of apoptosis in age-related skeletal muscle atrophy.

Authors:  Amie J Dirks; Christiaan Leeuwenburgh
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 2.  The role of apoptosis in neurodegenerative diseases.

Authors:  P Desjardins; S Ledoux
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

3.  STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells.

Authors:  Sujoy Bhattacharya; Ramesh M Ray; Leonard R Johnson
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

4.  Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient's Prognosis in Head and Neck Cancer.

Authors:  Xi-Hu Yang; Liu Liu; Yong-Jie Hu; Ping Zhang; Qin-Gang Hu
Journal:  Pathol Oncol Res       Date:  2018-11-12       Impact factor: 3.201

5.  Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation.

Authors:  Patrick Hundsdoerfer; Christian Thoma; Matthias W Hentze
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

6.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose.

Authors:  M Filippova; T A Brown-Bryan; C A Casiano; P J Duerksen-Hughes
Journal:  Cell Death Differ       Date:  2005-06-03       Impact factor: 15.828

7.  The BIR motifs mediate dominant interference and oligomerization of inhibitor of apoptosis Op-IAP.

Authors:  R R Hozak; G A Manji; P D Friesen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation.

Authors:  M Holcik; R G Korneluk
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.

Authors:  Dong Wan Kang; Chang Hwa Choi; Ji Yeon Park; Soo Kyung Kang; Yong Keun Kim
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

10.  Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells.

Authors:  Ji Cheon Jeong; Min Soo Kim; Thae Hyun Kim; Yong Keun Kim
Journal:  Neurochem Res       Date:  2008-10-24       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.